In pragmatic cluster randomized controlled trials (PCRCTs), healthcare providers are randomized, but intervention delivery and patient receipt may vary after assignment. In many PCRCTs, cluster-level implementation is measured using continuous implementation metrics, while individual compliance is recorded as a binary indicator. Standard complier average causal effect (CACE) estimands focus on individual-level compliance and do not account for heterogeneity in implementation across clusters. When intervention uptake is shaped by both cluster- and individual-level processes, it is of scientific interest to characterize how effects vary across these sources of compliance. We propose a Bayesian framework for PCRCTs with one-sided binary noncompliance at the individual level and one-sided partial compliance at the cluster level. The method uses a latent mixture model to summarize heterogeneity in cluster-level implementation based on baseline characteristics and treatment-arm implementation measures, and links these latent implementation strata to individual compliance and outcomes through a joint model. Because individual compliance and treatment-defined implementation measures are observed only under treatment assignment, the model imputes these quantities for control clusters and individuals assigned to control. The framework enables estimation of finite- and super-population intent-to-treat (ITT) and CACE estimands, both marginally and within latent implementation strata. We apply the method to the METRIcAL trial, a pragmatic cluster randomized study evaluating a personalized music intervention for nursing home residents with dementia. The analysis illustrates how accounting for implementation heterogeneity and individual compliance can provide insights beyond standard ITT analyses.
翻译:暂无翻译